Mohs surgery is often used to treat nonmelanoma skin cancer (NMSC), and its use among Medicare patients over the past decade has increased more than 200%.1 Mohs surgery has the unique ability to couple tissue conservation with complete microscopic margin control. However, most NMSC can be treated using various modalities, with varying recurrence rates, costs, and other outcomes, such as patient satisfaction. In an increasingly patient-oriented health care system, patient satisfaction is an important outcome for cancer therapies, especially for typically nonfatal conditions like NMSC. Patient satisfaction can be influenced by numerous variables, including patient demographics (age, gender, and race),2- 5 socioeconomic variables (education status, income, marital status, and site of care),6- 7 health status (physical health, mental health, skin-related quality of life [QOL], and worry),2,8- 10 tumor characteristics (size, type, location, and invasiveness),11 and previous experience with the disease. Satisfaction may also be influenced by intraoperative variables (number of stages, defect diameter, and repair type),12- 13 as well as by postoperative variables (complications, time lost for treatment, and perceived involvement in care). As an outcome measure, patient satisfaction has been associated with several other important outcomes, including health status, QOL, adherence to medical advice, and initiation of complaints.2,9- 10,14- 15 To improve patient satisfaction, it is important for clinicians to understand the factors that affect it.